John P. Hamill insider trades

Open-market stock purchases and sales by John P. Hamill, SrVP/CFO/Prin Fin & Acct Ofcr at Aprea Therapeutics, Inc, from SEC Form 4 filings since Aug 31, 2018.

Track record: 20% of 5 scored buys are up 5% or more since purchase, averaging -42%.

Recent trades

DateStockTradeValue
Mar 31, 2026APRE Aprea Therapeutics, IncBought$21.2K
Mar 12, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Mar 12, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Jan 30, 2026APRE Aprea Therapeutics, IncBought$4.4K
Dec 10, 2025APRE Aprea Therapeutics, IncBought$5.2K

Companies traded

  • APRE Aprea Therapeutics, Inc: 7 buys, last Mar 31, 2026
  • WINT Windtree Therapeutics Inc /de/: 4 buys, last Jul 26, 2022
  • TRVN Trevena Inc: 1 buy, last Jun 3, 2019

Get free alerts when John P. Hamill files a new trade →